Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors Benoit ChauvinSylvain DrouotAnne-Marie Taburet Review Article 24 May 2013 Pages: 815 - 831
The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs N. van LeeuwenJ. J. SwenL. M. ’t Hart Review Article 30 May 2013 Pages: 833 - 854
Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides Lei DiaoBernd Meibohm Review Article 30 May 2013 Pages: 855 - 868
Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations Tiphaine GoulenokBruno Fantin Review Article 27 June 2013 Pages: 869 - 883
The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression Ann Allen Original Research Article Open access 30 May 2013 Pages: 885 - 896
Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide Willi CawelloUwe FuhrAtef Halabi Original Research Article 05 June 2013 Pages: 897 - 906
Population Pharmacokinetic Analysis for Hydrocodone Following the Administration of Hydrocodone Bitartrate Extended-Release Capsules Murad R. MelhemChristopher M. RubinoCynthia Y. Robinson Original Research Article 30 May 2013 Pages: 907 - 917